Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Flecainide products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antiarrhythmic used to treat and prevent certain fast or irregular heart rhythms.
Products affected
1 / 8
In shortage since
Oct 31, 2025
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP FLECAINIDE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493705 · since Oct 31, 2025, est. end Jul 17, 2026 · Demand increase for the drug.
Resolved
APO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
Discontinued
NRA-FLECAINIDE
100MG · TABLET · NORA PHARMA INC
DIN 02530074
Discontinued
NRA-FLECAINIDE
50MG · TABLET · NORA PHARMA INC
DIN 02530066
Resolved
FLECAINIDE
100MG · TABLET · SANIS HEALTH INC
DIN 02534819 · ended Jan 22, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FLECAINIDE
100MG · TABLET · APOTEX INC
DIN 02275546 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-FLECAINIDE
100MG · TABLET · AURO PHARMA INC
DIN 02459965 · ended Jun 24, 2024 · Demand increase for the drug.
Resolved
APO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Feb 15, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FLECAINIDE
50MG · TABLET · APOTEX INC
DIN 02275538 · ended Sep 6, 2023 · Disruption of the manufacture of the drug.
Resolved
JAMP FLECAINIDE
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493705 · ended Feb 17, 2023 · Disruption of the manufacture of the drug.
Resolved
JAMP FLECAINIDE
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493713 · ended Feb 17, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Flecainide is currently affected by an active shortage report filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Flecainide is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BC).
Recent changes
No changes recorded yet.
Common questions
What is Flecainide used for?
An antiarrhythmic used to treat and prevent certain fast or irregular heart rhythms.
When will Flecainide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Flecainide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.